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DOI: http://dx.doi.org/10.1016/j.hemonc.2013.02.006We report a case of 53 year old female with history of acute myelogenous leukemia, for which she under-
went allogeneic peripheral blood stem cell transplant; her course was complicated by chronic graft versus
host disease. Seven years later she presents with squamous cell carcinoma of the skin which metastasize
to her heart. Here, in this case we tend to highlight the aggressive nature of the squamous cell carcinoma
in an immunocompromised individual.A53-year-old female patient presented to theclinic with a six-month history of dyspnea,recurrent pneumonia and nose bleeds. Bone
marrow biopsy was suggestive of Acute Myelogenous
Leukemia (AML). She was initially treated with cyt-
arabine and Idarubicin but had relapse of AML.
She subsequently underwent allogeneic peripheral
blood stem cell transplant, with her brother as the do-
nor. The course was complicated by chronic graft-ver-
sus-host disease (GVHD) of the skin for which
mycophenolate, tacrolimus and steroids were initi-
ated. However, the GVHD worsened and spread to
the skin, buccal mucosa and conjunctiva.
The patient was then started on IVIG therapy and
the GVHD resolved. Seven years later, during a regu-
lar clinical visit, she was found to have nodular lesion of
the right breast which revealed actinic keratosis. This
was treated with cryotherapy but failed to regress,
and the pathology showed well-differentiated squa-
mous cell carcinoma (Figure 1). Six months later, she
again developed recurrence of the squamous cell carci-
noma, this time in the right axilla and the shoulder. De-
spite several surgeries and skin grafts, the carcinoma
failed to regress and progressed into a large exophytic
tumor with skin ulceration. The skin biopsy showed
undifferentiated squamous cell carcinoma (Figure 2).
During treatment, the patient complained of short-
ness of breath and began to have hypotensive episodes.
A PET scan of the chest (Figures 3a and 3b) showed aHemass next to the right ventricle (18 · 15 mm) with
intense focal 18F-FDG (ﬂuorodeoxyglucose) uptake,
along with a left upper lobe lung nodule and a
separate medial right breast soft tissue nodule with
moderate FDG uptake, all consistent with metastatic
squamous cell carcinoma. She underwent radiation
therapy and was started on cisplatin and cetuximab che-
motherapy. After 11 cycles of the chemotherapy, MRI
showed regression of the cardiac mass (16 · 8 mm).
Unfortunately, the patient’s condition gradually wors-
ened and she succumbed to pulmonary emboli and se-
vere sepsis from the cellulites of the right arm and
expired eight years after the bone marrow transplant.DISCUSSION
Occurrence of squamous cell carcinoma in long term
survivors of bone marrow transplant recipients is well
documented.1,2 The average time period is around ﬁve
to eight years after the transplant. Risk factors include
chronic GVHD as seen in our case, immunosuppres-
sive treatments and radiation therapy. The most
common site of occurrence is the skin and the oral
cavity. Metastasis outside these locations is very rare.
This case highlights the aggressive nature of the
squamous cell carcinoma arising from the skin and
eventually metastasizing to areas outside the oral cav-
ity. In our patient, it was the chest wall and eventually
the heart.matol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.com
Figure 1. Well differentiated squamous cell carcinoma of the skin.
Figure 3a. PET SCAN: Intense FDG uptake within the right ventricular
wall.
Figure 3b. PET SCAN: Moderate FDG uptake in the right breast.
Figure 2. Poorly differentiated squamous cell carcinoma of the skin.
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